{"name":"Alta Partners","permalink":"alta-partners","crunchbase_url":"http://www.crunchbase.com/financial-organization/alta-partners","homepage_url":"http://www.altapartners.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"(415) 362-4022","description":"","email_address":"alta@altapartners.com","number_of_employees":null,"founded_year":1996,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Wed Jan 28 05:09:39 UTC 2009","updated_at":"Thu Jun 04 06:59:39 UTC 2009","overview":"<p>Alta Partners is a leading venture capital firm in life sciences, funding over 130 companies in the industry since 1996. Their diverse and integrated team brings together a powerful depth of knowledge and experience, delivering tangible results for their companies and their investors.</p>","image":{"available_sizes":[[[150,22],"assets/images/resized/0003/4978/34978v1-max-150x150.png"],[[168,25],"assets/images/resized/0003/4978/34978v1-max-250x250.png"],[[168,25],"assets/images/resized/0003/4978/34978v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"","address1":"One Embarcadero Center","address2":"37th Floor","zip_code":"94111","city":"San Francisco","state_code":"CA","country_code":"USA","latitude":37.794891,"longitude":-122.397901}],"relationships":[{"is_past":false,"title":"Co-Founder and Director","person":{"first_name":"Garrett","last_name":"Gruener","permalink":"garrett-gruener","image":{"available_sizes":[[[108,150],"assets/images/resized/0004/6616/46616v1-max-150x150.jpg"],[[144,200],"assets/images/resized/0004/6616/46616v1-max-250x250.jpg"],[[144,200],"assets/images/resized/0004/6616/46616v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Founding Partner and Managing Director","person":{"first_name":"Jean","last_name":"Deleage","permalink":"jean-deleage","image":{"available_sizes":[[[108,150],"assets/images/resized/0004/6615/46615v1-max-150x150.jpg"],[[144,200],"assets/images/resized/0004/6615/46615v1-max-250x250.jpg"],[[144,200],"assets/images/resized/0004/6615/46615v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Co-founder and Managing Director","person":{"first_name":"Guy","last_name":"P. Nohra","permalink":"guy-p-nohra","image":{"available_sizes":[[[108,150],"assets/images/resized/0004/6617/46617v1-max-150x150.jpg"],[[144,200],"assets/images/resized/0004/6617/46617v1-max-250x250.jpg"],[[144,200],"assets/images/resized/0004/6617/46617v1-max-450x450.jpg"]],"attribution":""}}}],"investments":[{"funding_round":{"round_code":"d","source_url":"http://www.thealarmclock.com/mt/archives/2007/05/post_284.html","source_description":"Carrier Ethernet's Xelerated Ventures Forth With $23M","raised_amount":23000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":5,"funded_day":8,"company":{"name":"Xelerated ","permalink":"xelerated","image":{"available_sizes":[[[150,39],"assets/images/resized/0003/4976/34976v1-max-150x150.png"],[[226,60],"assets/images/resized/0003/4976/34976v1-max-250x250.png"],[[226,60],"assets/images/resized/0003/4976/34976v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://venturebeat.com/2009/04/08/aerovance-inhales-38m-for-asthma-drugs/","source_description":"Aerovance inhales $38M for asthma drugs","raised_amount":38000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":4,"funded_day":7,"company":{"name":"Aerovance","permalink":"aerovance","image":{"available_sizes":[[[150,75],"assets/images/resized/0004/0827/40827v1-max-150x150.png"],[[218,109],"assets/images/resized/0004/0827/40827v1-max-250x250.png"],[[218,109],"assets/images/resized/0004/0827/40827v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.pehub.com/36508/vcs-pipe-435-million-to-sunesis-pharma/","source_description":"VCs PIPE $43.5 Million to Sunesis Pharma","raised_amount":43500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":4,"funded_day":7,"company":{"name":"Sunesis Pharmaceuticals","permalink":"sunesis-pharmaceuticals","image":{"available_sizes":[[[133,75],"assets/images/resized/0004/0936/40936v1-max-150x150.png"],[[133,75],"assets/images/resized/0004/0936/40936v1-max-250x250.png"],[[133,75],"assets/images/resized/0004/0936/40936v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.esperion.com/modules/news/article.php?storyid=1","source_description":"Esperion Therapeutics Completes $22.75M Series A Financing","raised_amount":22750000,"raised_currency_code":"USD","funded_year":2008,"funded_month":5,"funded_day":1,"company":{"name":"Esperion Therapeutics","permalink":"esperion-therapeutics","image":{"available_sizes":[[[121,40],"assets/images/resized/0004/6610/46610v1-max-150x150.png"],[[121,40],"assets/images/resized/0004/6610/46610v1-max-250x250.png"],[[121,40],"assets/images/resized/0004/6610/46610v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.avidrp.com/press_releases/05-21-09_Avid_Series_D.pdf","source_description":"Avid Radiopharmaceuticals Closes $34.5 Million Series D Financing","raised_amount":34500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":5,"funded_day":21,"company":{"name":"Avid Radiopharmaceuticals","permalink":"avid-radiopharmaceuticals","image":{"available_sizes":[[[150,50],"assets/images/resized/0004/8595/48595v2-max-150x150.png"],[[213,72],"assets/images/resized/0004/8595/48595v2-max-250x250.png"],[[213,72],"assets/images/resized/0004/8595/48595v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.trevenainc.com/news/index/trevena_announces_24_million_series_a_financing/","source_description":"Trevena, Inc. Announces $24 Million Series A Financing","raised_amount":24000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":3,"funded_day":1,"company":{"name":"Trevena","permalink":"trevena","image":{"available_sizes":[[[135,79],"assets/images/resized/0004/9263/49263v1-max-150x150.jpg"],[[135,79],"assets/images/resized/0004/9263/49263v1-max-250x250.jpg"],[[135,79],"assets/images/resized/0004/9263/49263v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.bizjournals.com/sanfrancisco/stories/2009/03/30/daily14.html","source_description":"Sutro Biopharma lands $15M with protein production","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":3,"funded_day":30,"company":{"name":"Sutro Biopharma","permalink":"sutro-biopharma","image":{"available_sizes":[[[139,102],"assets/images/resized/0011/0831/110831v1-max-150x150.png"],[[139,102],"assets/images/resized/0011/0831/110831v1-max-250x250.png"],[[139,102],"assets/images/resized/0011/0831/110831v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://deals.venturebeat.com/2007/03/28/aerovance-asthma-treatment-company-finishes-raising-60m/","source_description":"Aerovance, asthma treatment company, finishes raising $60M","raised_amount":60000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":3,"funded_day":28,"company":{"name":"Aerovance","permalink":"aerovance","image":{"available_sizes":[[[150,75],"assets/images/resized/0004/0827/40827v1-max-150x150.png"],[[218,109],"assets/images/resized/0004/0827/40827v1-max-250x250.png"],[[218,109],"assets/images/resized/0004/0827/40827v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.taligentherapeutics.com/press/080201Taligen_Series%20B.pdf","source_description":"Taligen Therapeutics Secures Series B Financing","raised_amount":65000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":1,"funded_day":1,"company":{"name":"Taligen Therapeutics","permalink":"taligen-therapeutics","image":{"available_sizes":[[[130,59],"assets/images/resized/0005/0041/50041v1-max-150x150.png"],[[130,59],"assets/images/resized/0005/0041/50041v1-max-250x250.png"],[[130,59],"assets/images/resized/0005/0041/50041v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/press-releases/intradigm-corporation-closes-final-tranche-21-4-million-series-b-financing-philip-haw","source_description":"Intradigm Corporation Closes Final Tranche of $21.4 Million Series B Financing; Philip Haworth, Ph.D. Appointed Chief Executive","raised_amount":21400000,"raised_currency_code":"USD","funded_year":2009,"funded_month":1,"funded_day":7,"company":{"name":"Intradigm Corporation","permalink":"intradigm-corporation","image":{"available_sizes":[[[150,34],"assets/images/resized/0005/0666/50666v1-max-150x150.png"],[[250,56],"assets/images/resized/0005/0666/50666v1-max-250x250.png"],[[316,72],"assets/images/resized/0005/0666/50666v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"","source_description":"Capital Report Index","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":5,"funded_day":5,"company":{"name":"Calistoga Pharmaceuticals","permalink":"calistoga-pharmaceuticals","image":{"available_sizes":[[[150,85],"assets/images/resized/0005/2159/52159v2-max-150x150.jpg"],[[217,124],"assets/images/resized/0005/2159/52159v2-max-250x250.jpg"],[[217,124],"assets/images/resized/0005/2159/52159v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://www.xelerated.com/templates/page.aspx?page_id=335","source_description":"Xelerated Closes $13 Million Funding Round  ","raised_amount":13000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":8,"funded_day":14,"company":{"name":"Xelerated ","permalink":"xelerated","image":{"available_sizes":[[[150,39],"assets/images/resized/0003/4976/34976v1-max-150x150.png"],[[226,60],"assets/images/resized/0003/4976/34976v1-max-250x250.png"],[[226,60],"assets/images/resized/0003/4976/34976v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://carbylan.com/carbylan_series_B_press_release_11-26-07.pdf","source_description":"Carbylan Announces $20 Million Series B Financing","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":11,"funded_day":26,"company":{"name":"Carbylan BioSurgery","permalink":"carbylan-biosurgery","image":{"available_sizes":[[[150,43],"assets/images/resized/0005/4083/54083v1-max-150x150.jpg"],[[250,71],"assets/images/resized/0005/4083/54083v1-max-250x250.jpg"],[[435,125],"assets/images/resized/0005/4083/54083v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.chemocentryx.com/news/2004/pr20040617.pdf","source_description":"ChemoCentryx Raises $33 Million in Private Financing","raised_amount":33000000,"raised_currency_code":"USD","funded_year":2004,"funded_month":6,"funded_day":17,"company":{"name":"ChemoCentryx","permalink":"chemocentryx","image":{"available_sizes":[[[127,77],"assets/images/resized/0005/4088/54088v1-max-150x150.jpg"],[[127,77],"assets/images/resized/0005/4088/54088v1-max-250x250.jpg"],[[127,77],"assets/images/resized/0005/4088/54088v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://www.fiercebiotech.com/story/vc-insiders-inject-16m-chimerix/2009-08-11?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0","source_description":"VC insiders inject $16M into Chimerix","raised_amount":16100000,"raised_currency_code":"USD","funded_year":2009,"funded_month":8,"funded_day":10,"company":{"name":"Chimerix","permalink":"chimerix","image":{"available_sizes":[[[150,60],"assets/images/resized/0005/6041/56041v1-max-150x150.png"],[[245,98],"assets/images/resized/0005/6041/56041v1-max-250x250.png"],[[245,98],"assets/images/resized/0005/6041/56041v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://deals.venturebeat.com/2008/07/27/sierra-surgical-raises-145m-for-female-sterilization/","source_description":"Sierra Surgical raises $14.5M for female sterilization","raised_amount":14500000,"raised_currency_code":"USD","funded_year":2008,"funded_month":7,"funded_day":27,"company":{"name":"Sierra Surgical","permalink":"sierra-surgical","image":null}}},{"funding_round":{"round_code":"unattributed","source_url":"http://deals.venturebeat.com/2008/06/20/vaccsys-raises-9-million-for-vaccine-research/","source_description":"Vaccsys raises $9 million for vaccine research","raised_amount":9000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":6,"funded_day":20,"company":{"name":"Vaccsys","permalink":"vaccsys","image":{"available_sizes":[[[150,22],"assets/images/resized/0005/9445/59445v1-max-150x150.png"],[[250,37],"assets/images/resized/0005/9445/59445v1-max-250x250.png"],[[450,67],"assets/images/resized/0005/9445/59445v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://deals.venturebeat.com/2007/08/15/sierra-surgical-raises-71m-for-female-sterilization-tech/","source_description":"Sierra Surgical raises $7.1M for female-sterilization tech","raised_amount":7100000,"raised_currency_code":"USD","funded_year":2007,"funded_month":8,"funded_day":15,"company":{"name":"Sierra Surgical","permalink":"sierra-surgical","image":null}}},{"funding_round":{"round_code":"d","source_url":"http://venturebeat.com/2007/06/29/paracor-raises-44m-for-heart-restraint/","source_description":"Paracor raises $44M for heart-failure device that restrains the heart","raised_amount":44000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":6,"funded_day":29,"company":{"name":"Paracor Medical","permalink":"paracor-medical","image":{"available_sizes":[[[150,45],"assets/images/resized/0005/9561/59561v1-max-150x150.jpg"],[[193,58],"assets/images/resized/0005/9561/59561v1-max-250x250.jpg"],[[193,58],"assets/images/resized/0005/9561/59561v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://deals.venturebeat.com/2007/03/22/chemocentryx-autoimmune-disease-drug-co-raises-2984m/","source_description":"ChemoCentryx, autoimmune disease drug co., raises $29.84M","raised_amount":29840000,"raised_currency_code":"USD","funded_year":2007,"funded_month":3,"funded_day":22,"company":{"name":"ChemoCentryx","permalink":"chemocentryx","image":{"available_sizes":[[[127,77],"assets/images/resized/0005/4088/54088v1-max-150x150.jpg"],[[127,77],"assets/images/resized/0005/4088/54088v1-max-250x250.jpg"],[[127,77],"assets/images/resized/0005/4088/54088v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://deals.venturebeat.com/2007/12/10/fundamental-applied-biology-raises-21m-for-making-cell-free-proteins/","source_description":"Fundamental Applied Biology raises $21M for making â€œcell-freeâ€ proteins","raised_amount":21000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":12,"funded_day":10,"company":{"name":"Fundamental Applied Biology","permalink":"fundamental-applied-biology","image":{"available_sizes":[[[150,13],"assets/images/resized/0005/9799/59799v1-max-150x150.png"],[[242,22],"assets/images/resized/0005/9799/59799v1-max-250x250.png"],[[242,22],"assets/images/resized/0005/9799/59799v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://deals.venturebeat.com/2007/02/20/sanuras-breat-tumor-device-company-raises-15m/","source_description":"Sanuras, breat tumor device company raises $15M","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":2,"funded_day":20,"company":{"name":"Sanarus Medical","permalink":"sanarus-medical","image":{"available_sizes":[[[150,51],"assets/images/resized/0005/9836/59836v1-max-150x150.png"],[[232,79],"assets/images/resized/0005/9836/59836v1-max-250x250.png"],[[232,79],"assets/images/resized/0005/9836/59836v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://deals.venturebeat.com/2007/03/29/coapt-systems-maker-of-aesthetic-surgery-implants-raises-226m-more/","source_description":"Coapt Systems, maker of aesthetic surgery implants, raises $22.6M more","raised_amount":22600000,"raised_currency_code":"USD","funded_year":2007,"funded_month":3,"funded_day":29,"company":{"name":"Coapt Systems","permalink":"coapt-systems","image":{"available_sizes":[[[80,94],"assets/images/resized/0005/9921/59921v1-max-150x150.jpg"],[[80,94],"assets/images/resized/0005/9921/59921v1-max-250x250.jpg"],[[80,94],"assets/images/resized/0005/9921/59921v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/atyr-pharma-inc-series-c-12m/","source_description":"aTyr Pharma, Inc.: Series C $12M","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":9,"funded_day":15,"company":{"name":"aTyr Pharma","permalink":"atyr-pharma","image":{"available_sizes":[[[150,128],"assets/images/resized/0006/0151/60151v1-max-150x150.png"],[[246,210],"assets/images/resized/0006/0151/60151v1-max-250x250.png"],[[246,210],"assets/images/resized/0006/0151/60151v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://deals.venturebeat.com/2007/03/20/intarcia-restarts-with-50m-for-hepatitis-diabetes-treatments/","source_description":"Intarcia restarts with $50M for hepatitis, diabetes treatments","raised_amount":null,"raised_currency_code":"USD","funded_year":2007,"funded_month":3,"funded_day":20,"company":{"name":"Intarcia Therapeutics","permalink":"intarcia-therapeutics","image":{"available_sizes":[[[150,85],"assets/images/resized/0006/2213/62213v1-max-150x150.png"],[[157,89],"assets/images/resized/0006/2213/62213v1-max-250x250.png"],[[157,89],"assets/images/resized/0006/2213/62213v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.Metabolex.com/news/nov052009.html","source_description":"Metabolex","raised_amount":8600000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":5,"company":{"name":"Metabolex","permalink":"metabolex","image":{"available_sizes":[[[150,23],"assets/images/resized/0006/5572/65572v1-max-150x150.jpg"],[[171,27],"assets/images/resized/0006/5572/65572v1-max-250x250.jpg"],[[171,27],"assets/images/resized/0006/5572/65572v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.Metabolex.com/news/apr192007.html","source_description":"Metabolex","raised_amount":32000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":4,"funded_day":19,"company":{"name":"Metabolex","permalink":"metabolex","image":{"available_sizes":[[[150,23],"assets/images/resized/0006/5572/65572v1-max-150x150.jpg"],[[171,27],"assets/images/resized/0006/5572/65572v1-max-250x250.jpg"],[[171,27],"assets/images/resized/0006/5572/65572v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.transmedics.com/wt/page/pr_1176415342","source_description":"TransMedics","raised_amount":25500000,"raised_currency_code":"USD","funded_year":2007,"funded_month":4,"funded_day":13,"company":{"name":"TransMedics","permalink":"transmedics","image":{"available_sizes":[[[150,34],"assets/images/resized/0006/8953/68953v1-max-150x150.png"],[[250,57],"assets/images/resized/0006/8953/68953v1-max-250x250.png"],[[282,65],"assets/images/resized/0006/8953/68953v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.transmedics.com/wt/page/pr_1127940262","source_description":"TransMedics","raised_amount":27600000,"raised_currency_code":"USD","funded_year":2004,"funded_month":1,"funded_day":27,"company":{"name":"TransMedics","permalink":"transmedics","image":{"available_sizes":[[[150,34],"assets/images/resized/0006/8953/68953v1-max-150x150.png"],[[250,57],"assets/images/resized/0006/8953/68953v1-max-250x250.png"],[[282,65],"assets/images/resized/0006/8953/68953v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.biospace.com/news_story.aspx?NewsEntityId=84511","source_description":"Sonexa Therapeutics, Inc. Raises $30 Million in Series A Financing to Focus on Alzheimer's Treatments","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":1,"funded_day":31,"company":{"name":"Sonexa Therapeutics","permalink":"sonexa-therapeutics","image":null}}},{"funding_round":{"round_code":"debt_round","source_url":"http://deals.venturebeat.com/2009/12/29/coapt-systems-takes-3-7m-for-facial-rejuvenation/","source_description":"Coapt Systems takes $3.7M for facial rejuvenation","raised_amount":3720000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":29,"company":{"name":"Coapt Systems","permalink":"coapt-systems","image":{"available_sizes":[[[80,94],"assets/images/resized/0005/9921/59921v1-max-150x150.jpg"],[[80,94],"assets/images/resized/0005/9921/59921v1-max-250x250.jpg"],[[80,94],"assets/images/resized/0005/9921/59921v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"debt_round","source_url":"http://deals.venturebeat.com/2010/01/14/virobay-raises-300k-to-treat-hepatitis-c-and-autoimmune-disorders/","source_description":"Virobay raises $300K to treat hepatitis C and autoimmune disorders","raised_amount":300000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":14,"company":{"name":"Virobay","permalink":"virobay","image":{"available_sizes":[[[150,37],"assets/images/resized/0007/4234/74234v1-max-150x150.jpg"],[[250,62],"assets/images/resized/0007/4234/74234v1-max-250x250.jpg"],[[261,65],"assets/images/resized/0007/4234/74234v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.venturedeal.com/News/2007/11/21/Agami-Systems-Raising-$50-Million-Funding","source_description":"Agami Systems Raising $50 Million Funding","raised_amount":50000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":11,"funded_day":21,"company":{"name":"agÃ¡mi Systems","permalink":"agmi-systems","image":null}}},{"funding_round":{"round_code":"c","source_url":"http://www.phenomixcorp.com/news-07-03-08.asp","source_description":"PHENOMIX COMPLETES $55 MILLION SERIES C FINANCING","raised_amount":55000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":3,"funded_day":8,"company":{"name":"Phenomix","permalink":"phenomix","image":{"available_sizes":[[[150,34],"assets/images/resized/0007/9903/79903v1-max-150x150.jpg"],[[211,48],"assets/images/resized/0007/9903/79903v1-max-250x250.jpg"],[[211,48],"assets/images/resized/0007/9903/79903v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.agensys.com/pressrelease_071207.html","source_description":"Agensys Raises $41 Million","raised_amount":41300000,"raised_currency_code":"USD","funded_year":2007,"funded_month":7,"funded_day":12,"company":{"name":"Agensys","permalink":"agensys","image":{"available_sizes":[[[149,65],"assets/images/resized/0007/9921/79921v1-max-150x150.jpg"],[[149,65],"assets/images/resized/0007/9921/79921v1-max-250x250.jpg"],[[149,65],"assets/images/resized/0007/9921/79921v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://altapartners.com/news_detail.php?id=215","source_description":"Ceregene Partners With Genzyme, Inks $28M Series C","raised_amount":28000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":6,"funded_day":22,"company":{"name":"Ceregene","permalink":"ceregene","image":{"available_sizes":[[[150,59],"assets/images/resized/0007/9928/79928v1-max-150x150.jpg"],[[250,98],"assets/images/resized/0007/9928/79928v1-max-250x250.jpg"],[[363,143],"assets/images/resized/0007/9928/79928v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://calistogapharma.com/pdf/CalistogaFinancing_March2007.pdf","source_description":"Calistoga Pharmaceuticals, a newly formed drug development company, announces its formation and completion of a $21 million Series A financing","raised_amount":21000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":3,"funded_day":5,"company":{"name":"Calistoga Pharmaceuticals","permalink":"calistoga-pharmaceuticals","image":{"available_sizes":[[[150,85],"assets/images/resized/0005/2159/52159v2-max-150x150.jpg"],[[217,124],"assets/images/resized/0005/2159/52159v2-max-250x250.jpg"],[[217,124],"assets/images/resized/0005/2159/52159v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://sutrobio.com/news/071210pr.html","source_description":"Fundamental Applied Biology, Inc. Completes $21 Million Series B Financing Daniel S. Gold, PhD, Joins as Chief Executive Officer","raised_amount":21000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":12,"funded_day":10,"company":{"name":"Sutro Biopharma","permalink":"sutro-biopharma","image":{"available_sizes":[[[139,102],"assets/images/resized/0011/0831/110831v1-max-150x150.png"],[[139,102],"assets/images/resized/0011/0831/110831v1-max-250x250.png"],[[139,102],"assets/images/resized/0011/0831/110831v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://excaliard.com/news/ISIS_News_2007_11_27_General_Releases.pdf","source_description":"Excaliard closes $15.5 million Series A financing from Alta Partners, ProQuest Investments and RiverVest Venture Partners","raised_amount":15500000,"raised_currency_code":"USD","funded_year":2007,"funded_month":11,"funded_day":27,"company":{"name":"Excaliard Pharmaceuticals","permalink":"excaliard-pharmaceuticals","image":{"available_sizes":[[[150,38],"assets/images/resized/0008/0196/80196v1-max-150x150.jpg"],[[250,64],"assets/images/resized/0008/0196/80196v1-max-250x250.jpg"],[[450,115],"assets/images/resized/0008/0196/80196v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://atyrpharma.com/index.php?option=com_content&view=article&id=8:april-18-2007&catid=3:archives&Itemid=25","source_description":"aTyr Pharma Completes $10.5M Series B Round","raised_amount":10500000,"raised_currency_code":"USD","funded_year":2007,"funded_month":4,"funded_day":18,"company":{"name":"aTyr Pharma","permalink":"atyr-pharma","image":{"available_sizes":[[[150,128],"assets/images/resized/0006/0151/60151v1-max-150x150.png"],[[246,210],"assets/images/resized/0006/0151/60151v1-max-250x250.png"],[[246,210],"assets/images/resized/0006/0151/60151v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":5000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":5,"funded_day":21,"company":{"name":"nCircle Network Security","permalink":"ncircle-network-security","image":{"available_sizes":[[[150,150],"assets/images/resized/0008/1729/81729v5-max-150x150.png"],[[250,250],"assets/images/resized/0008/1729/81729v5-max-250x250.png"],[[250,250],"assets/images/resized/0008/1729/81729v5-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://sanjose.bizjournals.com/sanjose/stories/2006/02/13/daily8.html","source_description":"Netli raises $18M funding","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":2,"funded_day":13,"company":{"name":"Netli","permalink":"netli","image":null}}},{"funding_round":{"round_code":"e","source_url":"http://onbiovc.com/transmedics-inc-series-e-36m/","source_description":"TransMedics, Inc.: Series E $36M","raised_amount":36000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":30,"company":{"name":"TransMedics","permalink":"transmedics","image":{"available_sizes":[[[150,34],"assets/images/resized/0006/8953/68953v1-max-150x150.png"],[[250,57],"assets/images/resized/0006/8953/68953v1-max-250x250.png"],[[282,65],"assets/images/resized/0006/8953/68953v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.pr-inside.com/achaogen-completes-56-million-series-c-r1817734.htm","source_description":"Achaogen Completes $56 Million Series C Financing ","raised_amount":56000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":7,"company":{"name":"Achaogen","permalink":"achaogen","image":{"available_sizes":[[[150,39],"assets/images/resized/0008/3158/83158v1-max-150x150.png"],[[197,52],"assets/images/resized/0008/3158/83158v1-max-250x250.png"],[[197,52],"assets/images/resized/0008/3158/83158v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":357000,"raised_currency_code":"USD","funded_year":2006,"funded_month":2,"funded_day":16,"company":{"name":"iSOCO","permalink":"isoco","image":{"available_sizes":[[[150,42],"assets/images/resized/0008/3847/83847v1-max-150x150.jpg"],[[164,47],"assets/images/resized/0008/3847/83847v1-max-250x250.jpg"],[[164,47],"assets/images/resized/0008/3847/83847v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://macrogenics.com/press_releases-244.html","source_description":"MacroGenics Raises $45M in Series C Financing - Company to Advance Monoclonal Antibody Clinical Programs","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":5,"funded_day":17,"company":{"name":"MacroGenics","permalink":"macrogenics","image":{"available_sizes":[[[150,95],"assets/images/resized/0005/9708/59708v1-max-150x150.jpg"],[[188,120],"assets/images/resized/0005/9708/59708v1-max-250x250.jpg"],[[188,120],"assets/images/resized/0005/9708/59708v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.thefreelibrary.com/Cara+Therapeutics+Secures+$19+Million+in+Series+C+Financing.-a0155078851","source_description":"Cara Therapeutics Secures $19 Million in Series C Financing.","raised_amount":19000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":11,"funded_day":28,"company":{"name":"Cara Therapeutics","permalink":"cara-therapeutics","image":{"available_sizes":[[[150,57],"assets/images/resized/0008/4286/84286v1-max-150x150.jpg"],[[197,76],"assets/images/resized/0008/4286/84286v1-max-250x250.jpg"],[[197,76],"assets/images/resized/0008/4286/84286v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.sarcode.com/about.html","source_description":"SARcode secured $25 million in financing ","raised_amount":29000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":12,"funded_day":1,"company":{"name":"SARcode Bioscience","permalink":"sarcode-corporation","image":{"available_sizes":[[[150,104],"assets/images/resized/0008/4418/84418v5-max-150x150.jpg"],[[250,174],"assets/images/resized/0008/4418/84418v5-max-250x250.jpg"],[[450,313],"assets/images/resized/0008/4418/84418v5-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://chemocentryx.com/news/2006/pr20060824b.html","source_description":"ChemoCentryx Completes Series C Financing","raised_amount":17700000,"raised_currency_code":"USD","funded_year":2006,"funded_month":8,"funded_day":24,"company":{"name":"ChemoCentryx","permalink":"chemocentryx","image":{"available_sizes":[[[127,77],"assets/images/resized/0005/4088/54088v1-max-150x150.jpg"],[[127,77],"assets/images/resized/0005/4088/54088v1-max-250x250.jpg"],[[127,77],"assets/images/resized/0005/4088/54088v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.intradigm.com/content/newsandevents/releases/112006.htm","source_description":"INTRADIGM ANNOUNCES SIGNIFICANT ENHANCEMENTS OF THE COMPANY CAPABILITIES, A NEW SERIES A FINANCING AND IMPORTANT ADDITION TO SENIOR MANAGEMENT TEAM","raised_amount":16000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":11,"funded_day":21,"company":{"name":"Intradigm Corporation","permalink":"intradigm-corporation","image":{"available_sizes":[[[150,34],"assets/images/resized/0005/0666/50666v1-max-150x150.png"],[[250,56],"assets/images/resized/0005/0666/50666v1-max-250x250.png"],[[316,72],"assets/images/resized/0005/0666/50666v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.redshiftsystems.com/site/Default.aspx?tabid=86","source_description":"RedShift Secures $12 Million in First-Round Financing","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":1,"funded_day":12,"company":{"name":"RedShift Systems","permalink":"redshift-systems","image":{"available_sizes":[[[145,84],"assets/images/resized/0008/7724/87724v1-max-150x150.jpg"],[[145,84],"assets/images/resized/0008/7724/87724v1-max-250x250.jpg"],[[145,84],"assets/images/resized/0008/7724/87724v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.aegislightwave.com/press_releases/release_4th_round.pdf","source_description":"Aegis Semiconductor Secures $8 Million in Series D Financing","raised_amount":8000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":3,"funded_day":1,"company":{"name":"Aegis Lightwave","permalink":"aegis-lightwave","image":{"available_sizes":[[[150,133],"assets/images/resized/0008/8865/88865v1-max-150x150.jpg"],[[160,142],"assets/images/resized/0008/8865/88865v1-max-250x250.jpg"],[[160,142],"assets/images/resized/0008/8865/88865v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.fiercebiotech.com/story/foldrx-banks-29m-neurodegenerative-drug-application/2010-06-15?utm_medium=rss&utm_source=rss","source_description":"FoldRx banks $29M for neurodegenerative drug application","raised_amount":29000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":15,"company":{"name":"Foldrx Pharmaceuticals","permalink":"foldrx-pharmaceuticals","image":null}}},{"funding_round":{"round_code":"unattributed","source_url":"http://deals.venturebeat.com/2010/06/16/drug-developer-virobay-brings-in-10m-for-hepatitis-c-treatments/","source_description":"Drug developer Virobay secures $10M for hepatitis C treatments","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":16,"company":{"name":"Virobay","permalink":"virobay","image":{"available_sizes":[[[150,37],"assets/images/resized/0007/4234/74234v1-max-150x150.jpg"],[[250,62],"assets/images/resized/0007/4234/74234v1-max-250x250.jpg"],[[261,65],"assets/images/resized/0007/4234/74234v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://onbiovc.com/nereus-pharmaceuticals-inc-series-e-20m/","source_description":"Nereus Pharmaceuticals, Inc.: Series E $20M","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":25,"company":{"name":"Nereus Pharmaceuticals","permalink":"nereus-pharmaceuticals","image":null}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/trevena-inc-series-b-35m/","source_description":"Trevena, Inc.: Series B $35M","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":7,"funded_day":14,"company":{"name":"Trevena","permalink":"trevena","image":{"available_sizes":[[[135,79],"assets/images/resized/0004/9263/49263v1-max-150x150.jpg"],[[135,79],"assets/images/resized/0004/9263/49263v1-max-250x250.jpg"],[[135,79],"assets/images/resized/0004/9263/49263v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.cerenis.com/media-detail.asp?id=253","source_description":"Cerenis Therapeutics raises EUR 40 million in series C financing","raised_amount":40000000,"raised_currency_code":"EUR","funded_year":2010,"funded_month":7,"funded_day":26,"company":{"name":"Cerenis Therapeutics","permalink":"cerenis-therapeutics","image":{"available_sizes":[[[150,64],"assets/images/resized/0010/6866/106866v1-max-150x150.png"],[[191,82],"assets/images/resized/0010/6866/106866v1-max-250x250.png"],[[191,82],"assets/images/resized/0010/6866/106866v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.xconomy.com/seattle/2010/07/26/immune-design-nabs-32m-for-targeted-vaccines/","source_description":"Immune Design Nabs $32M for Targeted Vaccines","raised_amount":32000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":7,"funded_day":26,"company":{"name":"Immune Design","permalink":"immune-design","image":{"available_sizes":[[[150,40],"assets/images/resized/0009/5060/95060v1-max-150x150.png"],[[220,60],"assets/images/resized/0009/5060/95060v1-max-250x250.png"],[[220,60],"assets/images/resized/0009/5060/95060v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.xconomy.com/boston/2008/07/07/immune-design-aiming-to-make-vaccines-that-work-better-in-a-single-shot/","source_description":"Immune Design Aiming To Make Vaccines That Work Better in a Single Shot","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":7,"funded_day":7,"company":{"name":"Immune Design","permalink":"immune-design","image":{"available_sizes":[[[150,40],"assets/images/resized/0009/5060/95060v1-max-150x150.png"],[[220,60],"assets/images/resized/0009/5060/95060v1-max-250x250.png"],[[220,60],"assets/images/resized/0009/5060/95060v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.calistogapharma.com/pdf/FINAL%20CALPharma%20Series%20C%20release%206.30.10.pdf","source_description":"Calistoga Pharmaceuticals Raises $40 Million in Series C Financing","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":30,"company":{"name":"Calistoga Pharmaceuticals","permalink":"calistoga-pharmaceuticals","image":{"available_sizes":[[[150,85],"assets/images/resized/0005/2159/52159v2-max-150x150.jpg"],[[217,124],"assets/images/resized/0005/2159/52159v2-max-250x250.jpg"],[[217,124],"assets/images/resized/0005/2159/52159v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.lifescientist.com.au/article/142987/opal_therapeutics_raises_6m_series_funding/","source_description":"Opal Therapeutics raises $6m in series A funding","raised_amount":6000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":10,"funded_day":31,"company":{"name":"OPAL Therapeutics","permalink":"opal-therapeutics","image":null}}},{"funding_round":{"round_code":"c","source_url":"http://www.xelerated.com/en/Xelerated-Lands-17-Million-in-New-Funding-.aspx","source_description":"Xelerated Lands $17 Million in New Funding","raised_amount":17000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":4,"funded_day":20,"company":{"name":"Xelerated ","permalink":"xelerated","image":{"available_sizes":[[[150,39],"assets/images/resized/0003/4976/34976v1-max-150x150.png"],[[226,60],"assets/images/resized/0003/4976/34976v1-max-250x250.png"],[[226,60],"assets/images/resized/0003/4976/34976v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32&aid=DJFVW00020101006e6a60008d&r=Rss&s=DJFVW","source_description":"Alta Partners Leads $30M Series C For Pathwork Diagnostics  ","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":6,"company":{"name":"Pathwork Diagnostics","permalink":"pathwork-diagnostics","image":{"available_sizes":[[[150,47],"assets/images/resized/0008/4707/84707v1-max-150x150.jpg"],[[211,67],"assets/images/resized/0008/4707/84707v1-max-250x250.jpg"],[[211,67],"assets/images/resized/0008/4707/84707v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.fiercebiotech.com/story/cara-rounds-15m-post-op-pain-drug/2010-07-21?utm_medium=rss&utm_source=rss","source_description":"Cara rounds up $15M for post-op pain drug  Read more: Cara rounds up $15M for post-op pain drug","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":7,"funded_day":21,"company":{"name":"Cara Therapeutics","permalink":"cara-therapeutics","image":{"available_sizes":[[[150,57],"assets/images/resized/0008/4286/84286v1-max-150x150.jpg"],[[197,76],"assets/images/resized/0008/4286/84286v1-max-250x250.jpg"],[[197,76],"assets/images/resized/0008/4286/84286v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2010/11/sutro-biopharma-secures-365m-in-series.html","source_description":"Sutro Biopharma Secures $36.5M in Series C Financing","raised_amount":36500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":11,"funded_day":17,"company":{"name":"Sutro Biopharma","permalink":"sutro-biopharma","image":{"available_sizes":[[[139,102],"assets/images/resized/0011/0831/110831v1-max-150x150.png"],[[139,102],"assets/images/resized/0011/0831/110831v1-max-250x250.png"],[[139,102],"assets/images/resized/0011/0831/110831v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.atyrpharma.com/index.php?option=com_content&view=article&id=29:october-26th-2010&catid=1:current-press-releases&Itemid=20","source_description":"aTyr Pharma Secures $23M Financing From Top Tier Venture Investor","raised_amount":23000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":26,"company":{"name":"aTyr Pharma","permalink":"atyr-pharma","image":{"available_sizes":[[[150,128],"assets/images/resized/0006/0151/60151v1-max-150x150.png"],[[246,210],"assets/images/resized/0006/0151/60151v1-max-250x250.png"],[[246,210],"assets/images/resized/0006/0151/60151v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2011/01/pneumrx-raises-33m.html","source_description":"PneumRx Raises $33M","raised_amount":33000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":1,"funded_day":4,"company":{"name":"PneumRx","permalink":"pneumrx","image":{"available_sizes":[[[150,61],"assets/images/resized/0011/6250/116250v1-max-150x150.png"],[[172,71],"assets/images/resized/0011/6250/116250v1-max-250x250.png"],[[172,71],"assets/images/resized/0011/6250/116250v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"f","source_url":"http://www.chimerix-inc.com/news-and-resources/news-and-resources-details/chimerix-completes-45-million-financing/","source_description":"Chimerix Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157 ","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":2,"funded_day":14,"company":{"name":"Chimerix","permalink":"chimerix","image":{"available_sizes":[[[150,60],"assets/images/resized/0005/6041/56041v1-max-150x150.png"],[[245,98],"assets/images/resized/0005/6041/56041v1-max-250x250.png"],[[245,98],"assets/images/resized/0005/6041/56041v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.aeriepharma.com/20110307_pressrelease.html","source_description":"Aerie Pharmaceuticals Completes $30 Million Series B Financing to Fund Further Development of Innovative Glaucoma Product Portfolio","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":3,"funded_day":7,"company":{"name":"Aerie Pharmaceuticals","permalink":"aerie-pharmaceuticals","image":{"available_sizes":[[[93,122],"assets/images/resized/0012/4935/124935v1-max-150x150.png"],[[93,122],"assets/images/resized/0012/4935/124935v1-max-250x250.png"],[[93,122],"assets/images/resized/0012/4935/124935v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2011/07/sarcode-bioscience-closes-44m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"SARcode Bioscience Closes $44M Series B Financing","raised_amount":44000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":7,"funded_day":18,"company":{"name":"SARcode Bioscience","permalink":"sarcode-corporation","image":{"available_sizes":[[[150,104],"assets/images/resized/0008/4418/84418v5-max-150x150.jpg"],[[250,174],"assets/images/resized/0008/4418/84418v5-max-250x250.jpg"],[[450,313],"assets/images/resized/0008/4418/84418v5-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://finance.yahoo.com/news/sutro-closes-16-5-million-113000166.html","source_description":"Sutro Closes $16.5 Million Second Tranche of Series C Financing","raised_amount":16500000,"raised_currency_code":"USD","funded_year":2012,"funded_month":5,"funded_day":8,"company":{"name":"Sutro Biopharma","permalink":"sutro-biopharma","image":{"available_sizes":[[[139,102],"assets/images/resized/0011/0831/110831v1-max-150x150.png"],[[139,102],"assets/images/resized/0011/0831/110831v1-max-250x250.png"],[[139,102],"assets/images/resized/0011/0831/110831v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.bizjournals.com/dallas/news/2012/10/23/zs-pharma-lands-46-million-for-kidney.html","source_description":"ZS Pharma lands $46 million for kidney and liver drug development","raised_amount":46000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":23,"company":{"name":"ZS Pharma","permalink":"zs-pharma","image":{"available_sizes":[[[150,38],"assets/images/resized/0021/7763/217763v1-max-150x150.png"],[[250,64],"assets/images/resized/0021/7763/217763v1-max-250x250.png"],[[252,65],"assets/images/resized/0021/7763/217763v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.biospace.com/News/applied-genetic-technologies-corporation-lands-37/280113/Source=TopBreaking","source_description":"Applied Genetic Technologies Corporation Lands $37.5 Million in Venture Capital Funding","raised_amount":37500000,"raised_currency_code":"USD","funded_year":2012,"funded_month":11,"funded_day":19,"company":{"name":"Applied Genetics Technologies Corporation","permalink":"applied-genetics-technologies-corporation","image":{"available_sizes":[[[133,150],"assets/images/resized/0004/8997/48997v1-max-150x150.png"],[[150,169],"assets/images/resized/0004/8997/48997v1-max-250x250.png"],[[150,169],"assets/images/resized/0004/8997/48997v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.masshightech.com/stories/2012/12/03/daily18-Obesity-drug-developer-Zafgen-raises-21M.html","source_description":"Obesity drug developer Zafgen raises $21M","raised_amount":21000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":12,"funded_day":4,"company":{"name":"Zafgen","permalink":"zafgen","image":{"available_sizes":[[[150,56],"assets/images/resized/0008/0171/80171v1-max-150x150.jpg"],[[250,93],"assets/images/resized/0008/0171/80171v1-max-250x250.jpg"],[[321,120],"assets/images/resized/0008/0171/80171v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[{"title":"","is_past":false,"provider":{"name":"Cooley ","permalink":"cooley-godward-kronish-llp","image":{"available_sizes":[[[150,54],"assets/images/resized/0009/4482/94482v2-max-150x150.jpg"],[[250,90],"assets/images/resized/0009/4482/94482v2-max-250x250.jpg"],[[429,155],"assets/images/resized/0009/4482/94482v2-max-450x450.jpg"]],"attribution":null}}}],"funds":[],"video_embeds":[],"external_links":[]}